Binding of SPAAT, the 44-residue C-terminal peptide of α1-antitrypsin, to proteins of the extracellular matrix

Journal of Cellular Biochemistry

Volumn 66, Issue 3, 1997, Pages 346-357

  Niemann, Marilyn A ^a   Baggott, Joseph E ^b   Miller, Edward J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

1 antitrypsin; Amgel; Collagen binding protein; Extracellular matrix binding protein; Laminin 1 binding protein; Matrigel

Indexed keywords

ALPHA 1 ANTITRYPSIN; CELL SURFACE PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; EXTRACELLULAR MATRIX; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

COLLAGEN; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; HUMANS; LAMININ; PEPTIDE FRAGMENTS; PROTEOGLYCANS; SUBSTRATE SPECIFICITY; TIME FACTORS;

EID: 0030878985     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970901)66:3<346::AID-JCB7>3.0.CO;2-P     Document Type: Article

References (48)

1. Andrews JL, Ghosh P (1990): Low molecular weight serine proteinase inhibitors of human articular cartilage. Arthritis Rheum 33:1384-1393.
2. Bar-Shavit R, Elder A, Vlodavsky I (1989): Binding of thrombin to subendothelial extracellular matrix. J Clin Invest 84:1096-1104.
3. Bashkin P, Doctron S, Klagsbrum M, Svahn CM, Folkman J, Vlodavsky I (1989): Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28:1737-1743.
4. Bissel MJ, Hall HG, Parry G (1982): How does the extracellular matrix direct gene expression? J Theor Biol 99: 31-68.
5. Brantly M, Nukina T, Crystal RG (1988): Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 84 (Suppl. 6A): 13-31.
6. Cambell A, Wicha MS, Lang M (1985): Extracellular matrix promotes the growth and differentiation of murine hematopoietic cells in vitro. J Clin Invest 75:2085-2090.
7. 14C] acetylated collagen. Anal Biochem 99:340-345.
8. Declerck PJ, DeMol M, Alessi M-C, Bauder S, Paques EP, Preissner KT, Muller-Berghaus G, Collen D (1988): Purification and characterization of a plasminogen activator inhibitor binding protein from human plasma. J Biol Chem 263:15454-15461.
9. Geboes K, Ray MB, Rutgeerts P, Callea F, Desmet VJ, Vantrappen G (1982): Morphological identification of alpha-1-antitrypsin in the human small intestine. Histopathology 6:55-60.
10. Highsmith RF (1981): Isolation and properties of a plasminogen activator derived from canine vascular tissue. J Biol Chem 256:6788-6795.
11. Huber AR, Weiss SJ (1989): Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J Clin Invest 83:1122-1136.
12. Humphries MJ, Olden K, Yamada KM (1986): A synthetic peptide from fibronection inhibits experimental metastasis of murine melanoma cells. Science 233:467-470.
13. Johnson-Witt B (1980): A quantitative collagen film collagenase assay for large numbers of samples. Anal Biochem 104:175-181.
14. Kay EP, Smith RE, Nimni ME (1985): Type I collagen synthesis by corneal endothelial cells modulated by polymorphonuclear leukocytes. J Biol Chem 260:5139-5146.
15. Kittas C, Aroni K, Kotsis L, Papadimitriou CS (1982a): Distribution of lysozyme, α1-antichymotrypsin and α1-antitrypsin in adenocarcinomas of the stomach and large intestine. Virchows Arch [A] 398:139-147.
16. Kittas C, Aroni K, Matani A, Papadimitriou C (1982b): Immunocytochemical demonstration of α1-antitrypsin and α1-antichymotrypsin in human gastrointestinal tract. Hepatogastroenterology 29:275-277.
17. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR (1986): Basement membrane complexes with biological activity. Biochemistry 25:312-318.
18. Knudsen BS, Silverstein RL, Leung LLK, Harpel PC, Nachman RL (1986): Binding of plasminogen to extracellular matrix. J Biol Chem 261:10765-10771.
19. Kushner I (1988): The acute phase response: An overview. Methods Enzymol 163:373-383.
20. LeBaron RG, Hook A, Esko JD, Gay S, Hook M (1989): Binding of heparan sulfate to type V collagen. A mechanism of cell-substrate adhesion. J Biol Chem 264:7950-7956.
21. Madri JA, Williams SK (1983): Capillary endothelial cell cultures: Phenotypic modulation by matrix components. J Cell Biol 97:153-165.
22. Majack RA, Cook CA, Bornsetin P (1985): Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol 101:1059-1070.
23. Miller EJ, Rhodes RK (1982): Preparation and characterization of the different types of collagen. Methods Enzymol 82A:33-64.
24. Mimuro J, Loskutoff DJ (1989): Purification of a protein from bovine plasma that binds to type I plasminogen activator inhibitor and prevents its interaction with extracellular matrix. J Biol Chem 264:936-939.
25. Molhuizen HOF, Alkemede HAC, Zeeuwen PLJM, deJongh GJ, Wieringa B, Schalkwijk J (1993): SKALP/Elafin: An elastase inhibitor from cultured keratinocytes. J Biol Chem 268:12028-12032.
26. Nielsen K (1984): Coeliac disease: Alpha-1-antitrypsin content in jejunal mucosa before and after gluten-free diet. Histopathology 8:759-764.
27. Niemann MA, Narkates AJ, Miller EJ (1992): Isolation and serine protease inhibitory activity of the 44-residue C-terminal fragment of α1-antitrypsin from human placenta. Matrix 12:233-241
28. Niemann MA, Baggott JE, Miller EJ (1997): Inhibition of human serine proteases by SPAAT, the C-terminal 44-residue peptide from α1-antitrypsin. Biochim Biophys Acta, in press.
29. Orkin RW, Gehron P, McGoodwin EB, Martin GR, Valentine T, Swarm R (1977): A murine tumor producing a matrix of basement membrane. J Exp Med 145:204-220.
30. Pei D, Majmudar G, Weiss SJ (1994): Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromeylsin-3. J Biol Chem 269:25849-25855.
31. Rao CN, Liu YY, Peavey CL, Woodley DT (1995a): Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts. Arch Biochem Biophys 317:311-314.
32. Rao CN, Gomez DE, Woodley DT, Thorgeirsson UP (1995b): Partial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells. Arch Biochem Biophys 319:55-62.
33. Ray MB, Desmet VJ, Gepts W (1977): Alpha-1-antitrypsin immunoreactivity in islet cells of adult human pancreas. Cell Tissue Res 185:63-68.
34. Ray MB, Geboes K, Callea F, Desmet VJ (1982): Alpha-1-antitrypsin immunoreactivity in gastric carcinoid. Histopathology 6:289-297.
35. Reich E (1978): Activation of plasminogen: A widespread mechanism for generating localized extracellular proteolysis. In Ruddon RW (ed): "Biological Markers of Neoplasia: Basic and Applied Aspects." Amsterdam: Elsevier/North Holland, pp 491-498.
36. Rice WG, Weiss SJ (1990): Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoproteinase inhibitor. Science 249:178-181.
37. Rinehart AR, Mallya S, Simon SR (1993): Human α1-proteinase inhibitor binds to extracellular matrix in vitro. Am J Respir Cell Mol Biol 9:666-679.
38. Schreiber G (1987): Synthesis, processing and secretion of plasma proteins by the liver and other organs and their regulation. In Putnam FW (ed): "The Plasma Proteins," 2nd ed, vol 5. New York: Academic, pp 292-363.
39. Sheela S, Barrett JC (1982): In vitro degradation of radiolabelled, intact basement membrane mediated by cellular plasminogen activator. Carcinogenesis (London) 3:363-369.
40. Siegal GP, Wang M-H, Rinehart Jr CA, Kennedy JW, Goodly LJ, Miller Y, Kaufman DG, Singh RK (1993): Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells. Cancer Lett 69:123-132.
41. Tahara E, Ito H, Taniyama K, Yokozaki H, Haita J (1984): Alpha1-antitrypsin, alpha1-antichymotrypsin, and al" pha2-macroglobulin in human gastric carcinomas. Hum Pathol 15:957-964.
42. Timpl R (1989): Structure and biological activity of base" ment membrane proteins. Eur J Biochem 180:487-502.
43. Vlodavsky I, Lui GM, Gospodarowicz D (1980): Morphologi" cal appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plastic. Cell 19:607-616.
44. Vlodavsky I, Fuks Z, Ishai-Michaeli R, Bashkin P, Levi E, Korner G, Bar-Shavit R, Klagsbrum M (1991): Extracel" lular matrix-resistant basic fibroblast growth factor: Im" plication for the control of angiogenesis. J Cell Biochem 45:167-176.
45. Wagner DD, Urban-Pickering M, Marden VJ (1984): von Willerbrand protein binds to extracellular matrices inde" pendently of collagen. Proc Natl Acad Sci USA 81:471-475.
46. Wiedow O, Schroder J-M, Gregory H, Young JA, Christophers E (1990): Elafin: An elastase-specific inhibitor of human skin. J Biol Chem 265:14791-14795.
47. Wittekind CH, Wachiner R, Henke W, Kleist S (1986): Localization of CEA, HCG, lysozyme, alpha-1-antitryp" sin and alpha-1-antichymotrypsin in gastric cancer and prognosis. Virchows Arch [A] 409:715-724.
48. Yurchenco PD, Schittny (1990): Molecular architecture of basement membranes. FASEB J 4:1577-1590.